**Core Concept**
Chronic gout is a form of inflammatory arthritis characterized by elevated serum uric acid levels, leading to deposition of monosodium urate crystals in joints. Management of chronic gout involves reducing uric acid levels, alleviating pain and inflammation, and preventing flares.

**Why the Correct Answer is Right**
The primary goal of gout treatment is to reduce serum uric acid levels and prevent further crystal deposition. Allopurinol and febuxostat are xanthine oxidase inhibitors that reduce uric acid production by inhibiting the enzyme xanthine oxidase. Probenecid increases uric acid excretion by the kidneys. Colchicine and NSAIDs are used to alleviate pain and inflammation associated with gout flares.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not directly address the pathophysiology of gout or the primary goal of gout treatment.
**Option B:** This option is incorrect because it does not directly address the pathophysiology of gout or the primary goal of gout treatment.
**Option C:** This option is incorrect because it does not directly address the pathophysiology of gout or the primary goal of gout treatment.
**Option D:** This option is incorrect because it does not directly address the pathophysiology of gout or the primary goal of gout treatment.

**Clinical Pearl / High-Yield Fact**
A commonly used mnemonic to remember the treatment goals for gout is "CARE": Control uric acid levels, Alleviate pain and inflammation, Reduce flares, and Educate patients on lifestyle modifications.

**Correct Answer: A.**